The footprint of TGF-β in airway remodeling of the mustard lung

References

• Adelipour M, Fooladi AAI, Yazdani S, et al (2011). Smad molecules expression pattern in human bronchial airway induced by sulfur mustard. Iran J Allergy Asthma Immunol 10:147–54
   PubMed Web of Science ®Google Scholar
• Aghanouri R, Ghanei M, Aslani J, et al (2004). Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 287:L1160–4
   PubMed Web of Science ®Google Scholar
• Akhurst RJ, Hata A. (2012). Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov 11:790–811
   PubMed Web of Science ®Google Scholar
• Al-Alawi M, Hassan T, Chotirmall SH. (2014). Transforming growth factor β and severe asthma: a perfect storm. Respir Med 108:1409–23
   PubMed Web of Science ®Google Scholar
• Amara N, Goven D, Prost F, et al (2010). NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65:733–8
   PubMed Web of Science ®Google Scholar
• Aoshiba K, Nagai A. (2004). Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Clin Rev Allergy Immunol 27:35–43
   PubMed Web of Science ®Google Scholar
• Ask K, Bonniaud P, Maass K, et al (2008). Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. Int J Biochem Cell Biol 40:484–95
   PubMed Web of Science ®Google Scholar
• Atkins KB, Lodhi IJ, Hurley LL, Hinshaw DB. (2000). N-acetylcysteine and endothelial cell injury by sulfur mustard. J Appl Toxicol 20:S125–8
   PubMedGoogle Scholar
• Balali-Mood M, Hefazi M. (2005). The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19:297–315
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. (2006). Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–82
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff MH, Dix TA. (1996). Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10:1077–83
   PubMed Web of Science ®Google Scholar
• Beheshti J, Mark EJ, Akbaei HM, et al (2006). Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202:739–44
   PubMed Web of Science ®Google Scholar
• Bergmann M, Tiroke A, Schafer H, et al (1998). Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J 32:97–103
   PubMed Web of Science ®Google Scholar
• Bijani K, Moghadamnia AA. (2002). Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf 53:422–4
   PubMed Web of Science ®Google Scholar
• Boulet LP, Laviolette M, Turcotte H, et al (1997). Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112:45–52
   PubMed Web of Science ®Google Scholar
• Camoretti-Mercado B, Solway J. (2005). Transforming growth factor-beta1 and disorders of the lung. Cell Biochem Biophys 43:131–48
   PubMed Web of Science ®Google Scholar
• Churg A, Cosio M, Wright JL. (2008). Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 294:L612–31
   PubMed Web of Science ®Google Scholar
• Cosio M, Ghezzo H, Hogg JC, et al (1978). The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:1277–81
   PubMed Web of Science ®Google Scholar
• Dacre JC, Goldman M. (1996). Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 48:289–326
   PubMed Web of Science ®Google Scholar
• Datta A, Scotton CJ, Chambers RC. (2011). Novel therapeutic approaches for pulmonary fibrosis. Br J Pharmacol 163:141–72
   PubMed Web of Science ®Google Scholar
• Derynck R, Akhurst RJ. (2007). Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 9:1000–4
   PubMed Web of Science ®Google Scholar
• Dubois CM, Laprise MH, Blanchette F, et al (1995). Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270:10618–24
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. (2007a). CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation. J Inflamm (Lond) 4:2. DOI: 10.1186/1476-9255-4-2
   PubMedGoogle Scholar
• Emad A, Emad Y. (2007b). Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 27:38–43
   PubMed Web of Science ®Google Scholar
• Emad A, Rezaian GR. (1997). The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 112:734–8
   PubMed Web of Science ®Google Scholar
• Emad A, Rezaian GR. (1999). Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115:1346–51
   PubMed Web of Science ®Google Scholar
• Engel ME, Mcdonnell MA, Law BK, Moses HL. (1999). Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274:37413–20
   PubMed Web of Science ®Google Scholar
• Fernandez IE, Eickelberg O. (2012). The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 9:111–16
   PubMedGoogle Scholar
• Gao X, Ray R, Xiao Y, et al (2010). Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm Pharmacol Ther 23:97–106
   PubMed Web of Science ®Google Scholar
• Ghanei M, Adibi I. (2007). Clinical review of mustard lung. IJMS 32:58–65
   Google Scholar
• Ghanei M, Moqadam FA, Mohammad MM, Aslani J. (2006). Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 173:304–9
   PubMed Web of Science ®Google Scholar
• Ghanei M, Fathi H, Mohammad MM, et al (2004a). Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 16:491–5
   PubMed Web of Science ®Google Scholar
• Ghanei M, Ghalejooghi NA, Nourani MR, et al (2010). Effect of TGFss1 and TIMP2 on disease activity in asthma and COPD. Iran J Allergy Asthma Immunol 9:79–86
   PubMed Web of Science ®Google Scholar
• Ghanei M, Harandi AA. (2007). Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19:451–6
   PubMed Web of Science ®Google Scholar
• Ghanei M, Harandi AA. (2011). Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol 23:363–71
   PubMed Web of Science ®Google Scholar
• Ghanei M, Khalili AR, Arab MJ, et al (2005). Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97:302–5
   PubMed Web of Science ®Google Scholar
• Ghanei M, Mokhtari M, Mohammad MM, Aslani J. (2004b). Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 52:164–9
   PubMed Web of Science ®Google Scholar
• Ghanei M, Tazelaar HD, Chilosi M, et al (2008). An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102:825–30
   PubMed Web of Science ®Google Scholar
• Gonzalez AV, Bellego FL, Ludwig MS. (2007). Imbalance of receptor-regulated and inhibitory Smads in lung fibroblasts from bleomycin-exposed rats. Am J Respir Cell Mol Biol 36:206–12
   PubMed Web of Science ®Google Scholar
• Gorska K, Maskey-Warzechowska M, Krenke R. (2010). Airway inflammation in chronic obstructive pulmonary disease. Curr Opin Pulm Med 16:89–96
   PubMed Web of Science ®Google Scholar
• Grainge CL, Lau LC, Ward JA, et al (2011). Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 364:2006–15
   PubMed Web of Science ®Google Scholar
• Gueli N, Verrusio W, Linguanti A, et al (2011). Montelukast therapy and psychological distress in chronic obstructive pulmonary disease (COPD): a preliminary report. Arch Gerontol Geriatr 52:e36–9
   PubMed Web of Science ®Google Scholar
• Hagimoto N, Kuwano K, Inoshima I, et al (2002). TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168:6470–8
   PubMed Web of Science ®Google Scholar
• Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q. (2011). Role of transforming growth factor-β in airway remodeling in asthma. Am J Respir Cell Mol Biol 44:127–33
   PubMed Web of Science ®Google Scholar
• Halwani R, Al-Muhsen S, Hamid Q. (2013). T helper 17 cells in airway diseases: from laboratory bench to bedside. Chest 143:494–501
   PubMed Web of Science ®Google Scholar
• Harkness LM, Kanabar V, Sharma HS, et al (2014). Pulmonary vascular changes in asthma and COPD. Pulm Pharmacol Ther 29:144–55
   PubMed Web of Science ®Google Scholar
• Heidarnejad H, Zendehdel N, Dastgiri S. (1998). Temporal trend of clinical and spirometric parameters in mustard gas victims: a ten year study. Arch Iran Med 1:6–13
   Google Scholar
• Henderson WR, Chiang JR, Tien GK, Chi YT. EY, (2006). Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 173:718–28
   PubMed Web of Science ®Google Scholar
• Hoffmann W. (2007). TFF (trefoil factor family) peptides and their potential roles for differentiation processes during airway remodeling. Curr Med Chem 14:2716–19
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Lu LF, Rudensky AY. (2012). Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531–64
   PubMed Web of Science ®Google Scholar
• Karami A, Ghanei M, Alaeddini F, et al (2011). Vascular endothelial growth factor in bronchoalveolar lavage fluid in sulfur mustard exposed lung patients. Oman Med J 26:118–21
   PubMedGoogle Scholar
• Katsuno Y, Lamouille S, Derynck R. (2013). TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25:76–84
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, Oenema TA, Meurs H, Gosens R. (2012). Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sci 91:1126–33
   PubMed Web of Science ®Google Scholar
• Klass BR, Grobbelaar AO, Rolfe KJ. (2009). Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J 85:9–14
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Liu X, Wen FQ, et al (2005). Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun 327:393–8
   PubMed Web of Science ®Google Scholar
• Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. (2012). TGF-β - an excellent servant but a bad master. J Transl Med 10:183. DOI: 10.1186/1479-5876-10-183
   PubMed Web of Science ®Google Scholar
• Laskin JD, Black AT, Jan YH, et al (2010). Oxidants and antioxidants in sulfur mustard-induced injury. Ann N Y Acad Sci 1203:92–100
   PubMed Web of Science ®Google Scholar
• Lee KS, Min KH, Kim SR, et al (2006). Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. Am J Respir Crit Care Med 174:161–70
   PubMed Web of Science ®Google Scholar
• Li MO, Sanjabi S, Flavell RA. (2006a). Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455–71
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Flavell RA. (2007). T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579–91
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Sanjabi S, et al (2006b). Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99–146
   PubMed Web of Science ®Google Scholar
• Lonning S, Mannick J, Mcpherson JM. (2011). Antibody targeting of TGF-β in cancer patients. Curr Pharm Biotechnol 12:2176–89
   PubMed Web of Science ®Google Scholar
• Massague J. (2008). TGFbeta in cancer. Cell 134:215–30
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Niimi A, Takemura M, et al (2005). Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma. Thorax 60:277–81
   PubMed Web of Science ®Google Scholar
• Mcdonald DM. (2001). Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:S39–45
   PubMed Web of Science ®Google Scholar
• Mehra A, Wrana JL. (2002). TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol 80:605–22
   PubMed Web of Science ®Google Scholar
• Mirzamani MS, Nourani MR, Fooladi I, et al (2013). Increased expression of transforming growth factor-beta and receptors in primary human airway fibroblasts from chemical inhalation patients. Iran J Allergy Asthma Immunol 12:144–52
   PubMed Web of Science ®Google Scholar
• Mishra NC, Rir-Sima-Ah J, Grotendorst GR, et al (2012). Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology. Int Immunopharmacol 13:101–8
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin CH. (2005). Non-smad TGF-beta signals. J Cell Sci 118:3573–84
   PubMed Web of Science ®Google Scholar
• Murray CS. (2008). Can inhaled corticosteroids influence the natural history of asthma? Curr Opin Allergy Clin Immunol 8:77–81
   PubMed Web of Science ®Google Scholar
• Naghii MR. (2002). Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med 167:573–5
   PubMed Web of Science ®Google Scholar
• Noble PW, Albera C, Bradford WZ, et al, (2011). Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377:1760–9
   PubMed Web of Science ®Google Scholar
• Pain M, Bermudez O, Lacoste P, et al (2014). Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. Eur Respir Rev 23:118–30
   PubMedGoogle Scholar
• Panahi Y, Ghanei M, Vahedi E, et al (2014). Effect of recombinant human IFNγ in the treatment of chronic pulmonary complications due to sulfur mustard intoxication. J Immunotoxicol 11:72–7
   PubMed Web of Science ®Google Scholar
• Panettieri RA. JR, (2003). Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir Physiol Neurobiol 137:277–93
   PubMed Web of Science ®Google Scholar
• Pennison M, Pasche B. (2007). Targeting transforming growth factor-beta signaling. Curr Opin Oncol 19:579–85
   PubMed Web of Science ®Google Scholar
• Postma DS, Timens W. (2006). Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:434–9
   PubMedGoogle Scholar
• Pourfarzam S, Yaraee R, Hassan ZM, et al (2013). Chemokines, MMP-9 and PMN elastase in spontaneous sputum of sulfur mustard exposed civilians: Sardasht-Iran cohort study. Int Immunopharmacol 17:958–63
   PubMed Web of Science ®Google Scholar
• Qian BF, Wahl SM. (2009). TGF-beta can leave you breathless. Curr Opin Pharmacol 9:454–61
   PubMed Web of Science ®Google Scholar
• Ramirez AM, Shen Z, Ritzenthaler JD, Roman J. (2006). Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways. Am J Transplant 6:2080–8
   PubMed Web of Science ®Google Scholar
• Razavi SM, Salamati P, Harandi AA, Ghanei M. (2013). Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties. Int J Prev Med 4:383–9
   PubMedGoogle Scholar
• Re SL, Lison D, Huaux F. (2013). CD4 + T lymphocytes in lung fibrosis: diverse subsets, diverse functions. J Leukoc Biol 93:499–510
   PubMed Web of Science ®Google Scholar
• Royce SG, Dang W, Yuan G, et al (2012). Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. Arch Immunol Ther Exp (Warsz) 60:295–306
   PubMed Web of Science ®Google Scholar
• Royce SG, Moodley Y, Samuel CS. (2014). Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Pharmacol Ther 141:250–60
   PubMed Web of Science ®Google Scholar
• Saeedi P, Salimian J, Ahmadi A, Fooladi AAI. (2015). The transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system. Inhal Toxicol 27:451–61
   PubMed Web of Science ®Google Scholar
• Samuel CS, Royce SG, Burton MD, et al (2007). Relaxin plays an important role in the regulation of airway structure and function. Endocrinol 148:4259–66
   PubMed Web of Science ®Google Scholar
• Santibanez JF, Quintanilla M, Bernabeu C. (2011). TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci 121:233–51
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S, Murphy-Ullrich JE. (1993). Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923–32
   PubMed Web of Science ®Google Scholar
• Sekiyama A, Gon Y, Terakado M, et al (2012). Glucocorticoids enhance airway epithelial barrier integrity. Int Immunopharmacol 12:350–7
   PubMed Web of Science ®Google Scholar
• Shahriary A, Mehrani H, Ghanei M, Parvin S. (2015). Comparative proteome analysis of peripheral neutrophils from sulfur mustard-exposed and COPD patients. J Immunotoxicol 12:132–9
   PubMed Web of Science ®Google Scholar
• Sheppard D. (2005). Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 24:395–402
   PubMed Web of Science ®Google Scholar
• Shi M, Zhu J, Wang R, et al (2011). Latent TGF-β structure and activation. Nature 474:343–9
   PubMed Web of Science ®Google Scholar
• Shohrati M, Ghanei M, Shamspour N, et al (2010). Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77–83
   PubMed Web of Science ®Google Scholar
• Shohrati M, Hosseini RH, Esfandiari MA, et al (2014). Serum matrix metalloproteinase levels in patients exposed to sulfur mustard. Iran Red Crescent Med J 16:e15129
   PubMed Web of Science ®Google Scholar
• Sourdeval M, Lemaire C, Deniaud A, et al (2006). Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 11:1545–59
   PubMed Web of Science ®Google Scholar
• Springer J, Scholz FR, Peiser C, et al (2004). SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem 385:649–53
   PubMed Web of Science ®Google Scholar
• Suzuki R, Miyazaki Y, Takagi K, et al (2004). Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy. Treat Respir Med 3:17–27
   PubMedGoogle Scholar
• Taipale J, Miyazono K, Heldin CH, Keski-Oja J. (1994). Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 124:171–81
   PubMed Web of Science ®Google Scholar
• Takizawa H, Tanaka M, Takami K, et al (2001). Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 163:1476–83
   PubMed Web of Science ®Google Scholar
• Thorley AJ, Tetley TD. (2007). Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2:409–28
   PubMedGoogle Scholar
• Trachtman H, Fervenza FC, Gipson DS, et al (2011). A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int 79:1236–43
   PubMed Web of Science ®Google Scholar
• Tschumperlin DJ, Drazen JM. (2001). Mechanical stimuli to airway remodeling. Am J Respir Crit Care Med 164:S90–4
   PubMedGoogle Scholar
• Undevia NS, Dorscheid DR, Marroquin BA, et al (2004). Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-beta1 in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 287:L515–24
   PubMed Web of Science ®Google Scholar
• Venkatesan N, Pini L, Ludwig MS. (2004). Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 287:L1342–7
   PubMed Web of Science ®Google Scholar
• Vignola AM, Mirabella F, Costanzo G, et al (2003). Airway remodeling in asthma. Chest 123:417S–22S
   PubMed Web of Science ®Google Scholar
• Warshamana GS, Pociask DA, Fisher KJ, et al (2002). Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice. Int J Exp Pathol 83:183–201
   PubMed Web of Science ®Google Scholar
• Wattana M, Bey T. (2009). Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp Disaster Med 24:19–29. discussion 30-1
   PubMedGoogle Scholar
• Wrana JL, Attisano L, Wieser R, et al (1994). Mechanism of activation of the TGF-beta receptor. Nature 370:341–7
   PubMed Web of Science ®Google Scholar
• Yu Q, Stamenkovic I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163–76
   PubMed Web of Science ®Google Scholar
• Zandvoort A, Postma DS, Jonker MR, et al (2006). Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J 28:533–41
   PubMed Web of Science ®Google Scholar
• Zarin AA, Behmanesh M, Tavallaei M, et al (2010). Overexpression of transforming growth factor (TGF)-beta1 and TGF-beta3 genes in lung of toxic-inhaled patients. Exp Lung Res 36:284–91
   PubMed Web of Science ®Google Scholar